glp 1 agonist action GLP-1 Receptor Agonists as Treatments for Type 2 Diabetes Mechanisms of GLP-1 Receptor Agonist-Induced

For weight management, the Food and Drug Administration (FDA) has approved two medications: Semaglutide (Wegovy) Tirzepatide (Zepbound) These drugs contain the same active ingredients as diabetes medications such as Ozempic and Mounjaro, but Wegovy and Zepbound are specifically approved for chronic weight management

IP ), sCT + liraglutide or vehicle (Fig

JAMA Intern Med 184(2):144152 Cena H, Chiovato L, Nappi RE (2020) Obesity, polycystic ovary syndrome, and infertility: a new avenue for GLP-1 receptor agonists

Integration of Digital Health Technologies The incorporation of digital health technologies into the GLP-1 Drug Market is gaining traction

N Engl J Med 2019;381:84151.PubMed 37